6- (1-Piperazinyl) -9-β-D-ribofuranosyl-9H-purine
Selected Variant
HY-152579
Size: 1 Each
6- (1-Piperazinyl) -9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
121370-61-4
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/6-1-piperazinyl-9-β-d-ribofuranosyl-9h-purine.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1[C@@H](O)[C@H](N2C(N=CN=C3N4CCNCC4)=C3N=C2)O[C@@H]1CO
Molecular Formula
C14H20N6O4
Molecular Weight
336.35
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1993), CF740 conjugate, 0.1mg/mL
CD68 (Macrophage Marker) (LAMP4/1830), CF740 conjugate, 0.1mg/mL
MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/2806), CF640R conjugate, 0.1mg/mL
Rb1 (Tumor Suppressor Protein) (RB1/2313R), CF640R conjugate, 0.1mg/mL
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B7), CF405S conjugate, 0.1mg/mL
